Cambridge Investment Research Advisors’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-21,880
| Closed | -$98K | – | 2187 |
|
|
2017
Q3 | $98K | Sell |
21,880
-1,250
| -5% | -$5.6K | ﹤0.01% | 1924 |
|
|
2017
Q2 | $106K | Buy |
23,130
+800
| +4% | +$3.67K | ﹤0.01% | 1846 |
|
|
2017
Q1 | $94K | Buy |
22,330
+200
| +0.9% | +$842 | ﹤0.01% | 1704 |
|
|
2016
Q4 | $91K | Sell |
22,130
-8,305
| -27% | -$34.2K | ﹤0.01% | 1596 |
|
|
2016
Q3 | $247K | Sell |
30,435
-2,075
| -6% | -$16.8K | ﹤0.01% | 1420 |
|
|
2016
Q2 | $254K | Sell |
32,510
-125
| -0.4% | -$977 | 0.01% | 1254 |
|
|
2016
Q1 | $252K | Sell |
32,635
-9,145
| -22% | -$70.6K | 0.01% | 1268 |
|
|
2015
Q4 | $451K | Buy |
41,780
+19,975
| +92% | +$216K | 0.01% | 895 |
|
|
2015
Q3 | $151K | Buy |
21,805
+9,150
| +72% | +$63.4K | ﹤0.01% | 1312 |
|
|
2015
Q2 | $112K | Buy |
12,655
+100
| +0.8% | +$885 | ﹤0.01% | 1364 |
|
|
2015
Q1 | $124K | Buy |
+12,555
| New | +$124K | ﹤0.01% | 1325 |
|